The elderly left behind—changes in survival trends of primary central nervous system lymphoma over the past 4 decades

Abstract

The poor outcome seen in the particularly vulnerable elderly patient population highlights the need for clinical trials targeting the elderly in hopes of improving treatment strategies and survival.